| Dr Gregory James Hall, MD | |
|
100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 | |
| (910) 450-3905 | |
| (910) 450-4558 |
| Full Name | Dr Gregory James Hall |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 100 Brewster Blvd, Camp Lejeune, North Carolina |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891858585 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
| Christus St Frances Cabrini Hospital | Alexandria, LA | Hospital |
| Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
| Union Hospital Inc | Terre haute, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiology Associates Of Southwest Louisiana | 0941243562 | 94 |
| Imaging Associates Of Indiana Pc | 1254503345 | 202 |
| Radiology Affiliates Of Central New Jersey P C | 1759277239 | 64 |
| Specialists In Medical Imaging Sc | 2163733544 | 201 |
| Louisville Radiology Imaging Consultants Pllc | 2264436120 | 54 |
| Empire State Radiology P C | 4385075241 | 175 |
| Northside Radiology Associates Llc | 4486555398 | 213 |
| Columbus Radiology Corp | 6507754983 | 271 |
| Adi Radiology Pc | 7911236427 | 67 |
| Coastal Radiology Associates Pllc | 8224002696 | 88 |
| Greensboro Radiology Pa | 8729074901 | 207 |
| Mori Bean And Brooks Inc | 8820077878 | 633 |
| Imaging Associates Of Michigan Pllc | 9537434386 | 66 |
| Empire State Radiology P C | 4385075241 | 175 |
| Hurley Medical Center | 2961308481 | 264 |
| Imaging Associates Of Michigan Pllc | 9537434386 | 66 |
| Murfreesboro Radiology And Nuclear Medicine Consultants Pllc | 7719964063 | 62 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Coastal Radiology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144270307 PECOS PAC ID: 8224002696 Enrollment ID: O20150513001736 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Columbus Radiology Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669408159 PECOS PAC ID: 6507754983 Enrollment ID: O20181107001886 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Louisville Radiology Imaging Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639115447 PECOS PAC ID: 2264436120 Enrollment ID: O20200219001670 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Southwest Diagnostic Imaging Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902896236 PECOS PAC ID: 7416946199 Enrollment ID: O20200507002040 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Radiology Associates Of Southwest Louisiana |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033215710 PECOS PAC ID: 0941243562 Enrollment ID: O20200508001977 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Empire State Radiology P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255962783 PECOS PAC ID: 4385075241 Enrollment ID: O20200512003135 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Mori Bean And Brooks Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20200522002661 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Singleton Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538107875 PECOS PAC ID: 6305731118 Enrollment ID: O20200622003065 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Sonoran Radiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033745708 PECOS PAC ID: 3375964505 Enrollment ID: O20200811000015 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Greensboro Radiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035999 PECOS PAC ID: 8729074901 Enrollment ID: O20200901000654 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Northside Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013960657 PECOS PAC ID: 4486555398 Enrollment ID: O20201007001000 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Specialists In Medical Imaging Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841687951 PECOS PAC ID: 2163733544 Enrollment ID: O20201021000795 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Imaging Associates Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699072611 PECOS PAC ID: 1254503345 Enrollment ID: O20201106000010 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Imaging Associates Of New Mexico Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629592464 PECOS PAC ID: 4981970233 Enrollment ID: O20201113001610 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Imaging Group Of Delaware Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164421574 PECOS PAC ID: 0547152472 Enrollment ID: O20211104002561 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Imaging Associates Of Michigan Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164943007 PECOS PAC ID: 9537434386 Enrollment ID: O20211124001450 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Radiology Affiliates Of Central New Jersey P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811994791 PECOS PAC ID: 1759277239 Enrollment ID: O20220131001640 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Entity Name | Adi Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083266761 PECOS PAC ID: 7911236427 Enrollment ID: O20231025003918 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory James Hall, MD 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 Ph: (910) 450-3905 | Dr Gregory James Hall, MD 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547-2538 Ph: (910) 450-3905 |
News Archive
A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.
It's too bad that ticker trouble doesn't guarantee good health elsewhere in the body. Most people with heart disease have other ailments, including some that require surgery.
Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected.
Understanding how a normal healthy cell turns into a cancerous one is our best bet yet for beating the disease. It will help better diagnose the cancer type, and enable the development of more effective, and less toxic therapies. But cells have evolved all sorts of sophisticated ways to become cancerous, and identifying the molecules involved and how they function in each type of cancer is a major undertaking.
› Verified 2 days ago
Antonino Germana, M.D., MPH Radiology Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4133 | |
Dr. Jinoh Sandberg, D.O Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 757-472-1298 | |
James J Mucciarone, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-4159 Fax: 910-450-4194 | |
Dr. Kristin Browske Wehrung, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 Brewster Blvd, Naval Hospital, Camp Lejeune, NC 28547 Phone: 910-450-4159 Fax: 910-450-4194 | |
Dr. Aaron M Taylor, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-450-4808 | |
Dr. Mark Morton, D.O. Radiology Medicare: Medicare Enrolled Practice Location: 100 Brewster Blvd, Naval Hospital Camp Lejeune, Camp Lejeune, NC 28547 Phone: 910-450-3398 | |
Dr. Robert Plympton Rutter Iv, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 Brewster Blvd, Camp Lejeune, NC 28547 Phone: 910-111-1111 |